5-Fluorouracil-based chemotherapy for colorectal cancer and MTHFR/MTRR genotypes

被引：89
|
作者：
Pardini, Barbara [1 ]
Kumar, Rajiv [2 ]
Naccarati, Alessio [1 ]
Novotny, Jan [3 ]
Prasad, Rashmi B. [2 ]
Forsti, Asta [2 ,4 ]
Hemminki, Kari [2 ,4 ]
Vodicka, Pavel [1 ]
Bermejo, Justo Lorenzo [2 ,5 ]
机构：
[1] Acad Sci Czech Republic, Inst Expt Med, Prague 14220 4, Czech Republic
[2] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany
[3] Charles Univ Prague, Fac Med 1, Prague, Czech Republic
[4] Lund Univ, Clin Res Ctr, Ctr Primary Hlth Care Res, Malmo, Sweden
[5] Univ Heidelberg Hosp, Inst Med Biometry & Informat, Heidelberg, Germany
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2011年 / 72卷 / 01期
关键词：
GENE POLYMORPHISMS; DNA-DAMAGE; FLUOROURACIL; CYTOTOXICITY; RESISTANCE; MECHANISMS; CELLS;
D O I：
10.1111/j.1365-2125.2010.03892.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：162 / 163
页数：2
相关论文
共 50 条
  • [31] Palliative 5-fluorouracil-based chemotherapy for advanced colorectal cancer in the elderly -: Results of a 10-year experience
    Magné, N
    François, E
    Broisin, L
    Guardiola, E
    Ramaïoli, A
    Ferrero, JM
    Namer, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (02): : 126 - 130
  • [32] GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy
    Wang, Zaozao
    Jiang, Beihai
    Chen, Lei
    Di, Jiabo
    Cui, Ming
    Liu, Maoxing
    Ma, Yiyuan
    Yang, Hong
    Xing, Jiadi
    Zhang, Chenghai
    Yao, Zhendan
    Zhang, Nan
    Dong, Bin
    Ji, Jiafu
    Su, Xiangqian
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [33] Paclitaxel and cisplatin combination chemotherapy for advanced gastric cancer failed to 5-fluorouracil-based chemotherapy
    Kim, Y.
    Kim, M.
    Lee, S. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] Melatonin increases the effect of 5-fluorouracil-based chemotherapy in human colorectal adenocarcinoma cells in vitro
    Pariente, Roberto
    Bejarano, Ignacio
    Beatriz Rodriguez, Ana
    Antonio Pariente, Jose
    Espino, Javier
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2018, 440 (1-2) : 43 - 51
  • [35] Predictors of toxicity-related hospitalization in four randomized studies of 5-fluorouracil-based chemotherapy in metastatic colorectal cancer
    Omar Abdel-Rahman
    Osama Ahmed
    International Journal of Colorectal Disease, 2019, 34 : 675 - 680
  • [36] Topoisomerase I and IIα protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy
    Tsavaris, Nicolas
    Lazaris, Andreas
    Kosmas, Christos
    Gouveris, Panagiotis
    Kavantzas, Nikolaos
    Kopterides, Petros
    Papathomas, Thomas
    Arapogiannis, George
    Zorzos, Haralambos
    Kyriakou, Vassiliki
    Patsouris, Efstathios
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 391 - 398
  • [37] Association between poorly differentiated clusters and efficacy of 5-fluorouracil-based adjuvant chemotherapy in stage III colorectal cancer
    Tajima, Yosuke
    Shimada, Yoshifumi
    Kameyama, Hitoshi
    Yagi, Ryoma
    Okamura, Takuma
    Kobayashi, Takashi
    Kosugi, Shin-ichi
    Wakai, Toshifumi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (04) : 313 - 320
  • [38] Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids
    Sabeti Aghabozorgi, Amirsaeed
    Moradi Sarabi, Mostafa
    Jafarzadeh-Esfehani, Reza
    Koochakkhani, Shabnaz
    Hassanzadeh, Marziyeh
    Kavousipour, Soudabeh
    Eftekhar, Ebrahim
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (09) : 942 - 956
  • [39] Melatonin increases the effect of 5-fluorouracil-based chemotherapy in human colorectal adenocarcinoma cells in vitro
    Roberto Pariente
    Ignacio Bejarano
    Ana Beatriz Rodríguez
    José Antonio Pariente
    Javier Espino
    Molecular and Cellular Biochemistry, 2018, 440 : 43 - 51
  • [40] Topoisomerase I and IIα protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy
    Nicolas Tsavaris
    Andreas Lazaris
    Christos Kosmas
    Panagiotis Gouveris
    Nikolaos Kavantzas
    Petros Kopterides
    Thomas Papathomas
    George Agrogiannis
    Haralambos Zorzos
    Vassiliki Kyriakou
    Efstratios Patsouris
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 399 - 399
12345